This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.
Since January 1, Marcus & Millichap, Inc. (MMI) has climbed 51.5%. Marcus & Millichap, a brokerage company, provides various investment brokerage and financing services to sellers and buyers of various types and sizes of commercial real estate properties in the United States. For more information, get Portfolio Grader’s complete analysis of MMI stock.
Since January 1, the price of Impax Laboratories, Inc. (IPXL) has grown 55.3%. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPXL stock.
The price of Insperity, Inc. (NSP) has seen a 56.3% boost since the first of the year. Insperity provides personnel management that encompasses a range of services, including benefits and payroll administration, health and workers’ compensation insurance programs and personnel records management. For more information, get Portfolio Grader’s complete analysis of NSP stock.
Since the first of the year, the price of Ellie Mae, Inc. (ELLI) has swelled 59.5%. Ellie Mae provides business automation software for the mortgage industry in the United States. Trade volume rose notably over the past week, up 159.6%. For more information, get Portfolio Grader’s complete analysis of ELLI stock.
Since January 1, Teekay Tankers Ltd. Class A (TNK) has climbed 59.6%. Teekay Tankers owns oil tankers and transports crude oil. For more information, get Portfolio Grader’s complete analysis of TNK stock.
Shares of ABIOMED, Inc. (ABMD) have risen 73.8% since January 1. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.
China Biologic Products, Inc. (CBPO) has risen 76.8% since the first of the year. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. Trade volume has increased significantly over the past week, up 269.5%. For more information, get Portfolio Grader’s complete analysis of CBPO stock.
Shares of Skechers U.S.A., Inc. Class A (SKX) have leaped 94.3% since January 1. Skechers USA designs, makes, markets and distributes footwear. For more information, get Portfolio Grader’s complete analysis of SKX stock.
The price of Ebix, Inc. (EBIX) is up 108.4% since the first of the year. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. Trade volume rose notably over the past week, up 155.7%. For more information, get Portfolio Grader’s complete analysis of EBIX stock.
Since January 1, Chimera Investment Corporation (CIM) has jumped 311.8%. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock currently has a trailing PE Ratio of 5.40. For more information, get Portfolio Grader’s complete analysis of CIM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
